Home-Based Remedies to Prevent COVID-19-Associated Risk of Infection, Admission, Severe Disease, and Death: A Nested Case-Control Study
Table 4
Logistic regression showing the odds of infection, severe disease, admission, and death associated with the administration of any home-based remedy to prevent COVID-19.
Characteristics
Univariate logistic regression
Multivariate logistic regression
AOR [95% CI]
value
OR [95% CI]
value
Risk of PCR-positive SARS-CoV-2 test
0.28 [0.20–0.39]
<0.001
0.38 [0.26–0.57]
<0.001
Risk of severe or critical COVID-19
0.15 [0.05–0.48]
0.002
0.40 [0.11–1.48]
0.169
Risk of admission
0.15 [0.06–0.38]
<0.001
0.29 [0.11–0.74]
0.009
Risk of death from COVID-19
0.31 [0.07–1.38]
0.124
2.82 [0.60–13.3]
0.189
Sex
Female
—
Male
1.14 [0.86–1.54]
0.358
Age (years)
Less than 20
—
20–29
2.19 [0.99–4.88]
0.054
30–39
2.37 [1.12–5.47]
0.025
40–49
1.99 [0.82–4.79]
0.127
50–59
2.16 [0.83–5.65]
0.115
60 and above
0.57 [0.09–0.43]
<0.001
Healthcare worker status
Healthcare professional
—
Nonhealthcare worker
2.14 [1.56–2.93]
<0.001
Face mask use within last two weeks
Use any type of facemask
—
Did not use face mask
0.17 [0.06–0.46]
0.001
Use of immune boosters
Did not take immune boosters
—
Took immune boosters
2.65 [1.97–3.58]
<0.001
AOR: adjusting for age, mask use, intake of immune booster, and healthcare worker status. Risk of infection and admission were associated with the method of administration of home-based remedies to prevent COVID-19.
